Phio Pharmaceuticals (PHIO) Net Margin (2016 - 2019)
Historic Net Margin for Phio Pharmaceuticals (PHIO) over the last 8 years, with Q1 2019 value amounting to 10219.05%.
- Phio Pharmaceuticals' Net Margin fell 4842700.0% to 10219.05% in Q1 2019 from the same period last year, while for Dec 2019 it was 42795.24%, marking a year-over-year decrease of 374619000.0%. This contributed to the annual value of 42419.05% for FY2019, which is 370857100.0% down from last year.
- Phio Pharmaceuticals' Net Margin amounted to 10219.05% in Q1 2019, which was down 4842700.0% from 2619.3% recorded in Q3 2018.
- In the past 5 years, Phio Pharmaceuticals' Net Margin registered a high of 2619.3% during Q3 2018, and its lowest value of 24577.78% during Q2 2016.
- Over the past 5 years, Phio Pharmaceuticals' median Net Margin value was 9976.92% (recorded in 2018), while the average stood at 11911.38%.
- Its Net Margin has fluctuated over the past 5 years, first surged by 47217000bps in 2015, then tumbled by -131041200bps in 2016.
- Over the past 5 years, Phio Pharmaceuticals' Net Margin (Quarter) stood at 9205.88% in 2015, then tumbled by -167bps to 24577.78% in 2016, then soared by 46bps to 13346.67% in 2017, then soared by 80bps to 2619.3% in 2018, then crashed by -290bps to 10219.05% in 2019.
- Its last three reported values are 10219.05% in Q1 2019, 2619.3% for Q3 2018, and 3277.59% during Q2 2018.